Article
TP53 Gene Therapy as a Potential Treatment for Patients with COVID-19
31 Mar 2022
Abstract excerpt
gene that encodes wild-type human p53. SGT-53 is currently in phase II human trials for advanced pancreatic cancer. Although p53 is best known as a tumor suppressor, its participation in both innate and adaptive immune responses is well documented. It is now clear that p53 is an important component of the host response to various viral infections. To facilitate their viral life cycles, viruses have developed a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
